See also this year's filing and all EDGAR filings for this company.
PDF Report 0000880771_2016_Sciclone_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000880771, Sciclone Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 168,521,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 32,979,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,651,000 |
| 3 | remainder_Assets | 12,468,000 |
| 4 | LiabilitiesCurrent | 36,820,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 27,897,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 100,256,000 |
| 11 | remainder_Revenues | 157,257,000 |
| 12 | remainder_NetIncome | 359,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,194,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 216,619,000 |
| 1 | Liabilities | 36,820,000 |
| 2 | Expenses | 128,153,000 |
| 3 | Revenues | 157,257,000 |
| 4 | StockholdersEquity | 179,799,000 |
| 5 | NetIncome | 29,463,000 |
| 6 | ComprehensiveNetIncome | 28,866,000 |
| 7 | BaseVar | 270,201,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.32 |
| 9 | EconomicCapitalRatio | 3.90 |
Edgar->Model Mapping
Feature Distribution
